Literature DB >> 23819700

Partial and radical nephrectomy provide comparable long-term cancer control for T1b renal cell carcinoma.

Malek Meskawi1, Andreas Becker, Marco Bianchi, Quoc-Dien Trinh, Florian Roghmann, Zhe Tian, Markus Graefen, Paul Perrotte, Pierre I Karakiewicz, Maxine Sun.   

Abstract

OBJECTIVES: To examine utilization rates of partial nephrectomy relative to radical nephrectomy for T1b renal cell carcinoma in contemporary years, to identify sociodemographic and disease characteristics associated with partial nephrectomy use, and to compare effectiveness of partial versus radical nephrectomy with respect to cancer control.
METHODS: Using the Surveillance, Epidemiology, and End Results database, 16,333 patients treated with partial or radical nephrectomy for T1bN0M0 renal cell carcinoma between 1988 and 2008 were identified. Logistic regression models were carried out to identify determinants of partial nephrectomy. Subsequently, cumulative incidence rates of cancer-specific and other-cause mortality between partial and radical nephrectomy were assessed, within the matched cohort. Furthermore, competing-risks regression analyses were used for prediction of cancer-specific mortality, after adjusting for other-cause mortality, and vice versa.
RESULTS: The utilization rate of partial nephrectomy increased from 1.2% in 1988 to 15.9% in 2008 (P < 0.001). Younger individuals, smaller tumors, persons of black race, as well as men, were more likely to be treated with partial nephrectomy in the current cohort (all P ≤ 0.002). In the post-propensity cohort, the 5- and 10-year cancer-specific mortality rates were 4.4 and 6.1% for partial versus 6.0 and 10.4% for radical nephrectomy, respectively (P = 0.03). Competing-risks regression analyses showed that nephrectomy type was not statistically significantly associated with cancer-specific mortality, even after adjusting for other-cause mortality (hazard ratio 0.89, P = 0.5).
CONCLUSIONS: Despite providing a comparable cancer control, the use of partial over radical nephrectomy for T1b renal cell carcinoma in USA has remained limited in recent years.
© 2013 The Japanese Urological Association.

Entities:  

Keywords:  competing-risk analyses; partial nephrectomy; renal cell carcinoma and T1b

Mesh:

Year:  2013        PMID: 23819700     DOI: 10.1111/iju.12204

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  11 in total

1.  Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.

Authors:  Raouf Seyam; Mahmoud I Khalil; Mohamed H Kamel; Waleed M Altaweel; Rodney Davis; Nabil K Bissada
Journal:  Int Urol Nephrol       Date:  2019-01-08       Impact factor: 2.370

2.  Survival analysis of surgically treated renal cell carcinoma: a single Chinese medical center experience from 2002 to 2012.

Authors:  Yushi Zhang; Hongyan Yu; Hanzhong Li
Journal:  Int Urol Nephrol       Date:  2015-07-11       Impact factor: 2.370

3.  [Indications for nephron-sparing surgery. Analysis over a 13-year period in the context of changing guidelines].

Authors:  P J Olbert; M Maier; H Heers; A Hegele; R Hofmann
Journal:  Urologe A       Date:  2015-06       Impact factor: 0.639

4.  Use of biological Glue (Bioglue®) in laparoscopic partial nephrectomy: a study in pigs.

Authors:  Luis Felipe Brandão; Fabio Cesar Miranda Torricelli; Glauco Melo; Luiz Cesar Fernando Takano; Anuar Ibrahim Mitre; Marco Antonio Arap
Journal:  Int Braz J Urol       Date:  2015 Mar-Apr       Impact factor: 1.541

5.  Nephron Sparing Surgery Has Better Oncologic Outcomes Than Extirpative Nephrectomy in T1a but Not in T1b or T2 Stage Renal Cell Carcinoma.

Authors:  You Luo; San-San Chen; Liang Bai; Li Luo; Xiang-Guang Zheng; Sen Wang
Journal:  Med Sci Monit       Date:  2017-07-18

6.  Renal Autotransplantation and Extracorporeal Nephron-Sparing Surgery for De Novo Renal Cell Carcinoma in a Kidney Allograft.

Authors:  Shinichiro Ono; Takashi Kenmochi; Taihei Ito; Naohiro Aida; Kazunori Otsuki; Naotake Akutsu; Michihiro Maruyama; Mamoru Kusaka; Ryoichi Shiroki; Kiyotaka Hoshinaga
Journal:  Transplant Direct       Date:  2017-07-24

7.  Comparison of the long-term follow-up and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Yu-Li Jiang; Cheng-Xia Peng; Heng-Zi Wang; Lu-Jie Qian
Journal:  BMC Urol       Date:  2019-06-07       Impact factor: 2.264

Review 8.  Comparison of the oncological, perioperative and functional outcomes of partial nephrectomy versus radical nephrectomy for clinical T1b renal cell carcinoma: A systematic review and meta-analysis of retrospective studies.

Authors:  Yucong Zhang; Gongwei Long; Haojie Shang; Beichen Ding; Guoliang Sun; Wei Ouyang; Man Liu; Yuan Chen; Heng Li; Hua Xu; Zhangqun Ye
Journal:  Asian J Urol       Date:  2019-12-04

9.  Robot-assisted laparoscopic partial nephrectomy is a safe and effective option for clinical T2 renal cell carcinoma: a case-series from single-institution.

Authors:  Gongwei Long; Man Liu; Yucong Zhang; Guoliang Sun; Wei Ouyang; Jun Yang; Zhihua Wang; Zheng Liu; Wei Guan; Zhiquan Hu; Shaogang Wang; Heng Li
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

10.  Functional, oncological outcomes and safety of nephron-sparing surgery versus radical nephrectomy in patients with localised renal cell carcinoma with high anatomical complexity: a retrospective cohort study with propensity score matching method.

Authors:  Xuanyu Zhang; Zhonghua Su; Peng Lv; Zeqi Liu; Song Bai
Journal:  BMJ Open       Date:  2021-12-24       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.